The US vaping crisis ensnared another tobacco company as Imperial Brands said earnings growth ground to a halt after a drastic slowdown in revenue from smoking alternatives.
The warning from the maker of Blu vaping devices adds to the fallout from a backlash against e-cigarettes that has already scuttled the biggest potential merger in the industry. Imperial’s shares plunged as much as 12% on Thursday, on track for a record decline.
"It calls Imperial Brands’ and the tobacco industry’s longer-term business model into question," said James Edwardes Jones, an analyst at RBC. "The implications should not be under-estimated."
Early signs of health risks, missed or ignored
Imperial’s warning comes a day after Altria Group abandoned talks on a possible merger with Philip Morris International and installed one of its own executives at the helm of embattled e-cigarette maker Juul Labs.
US health officials are scrambling to identify a mystery illness linked to vaping, denting prospects for what had become one of the biggest new growth markets in the industry. Consumers are now questioning the devices, touted to carry fewer health risks than traditional cigarettes.
Imperial Brands, the smallest of the major tobacco companies, has lost more than half its market value from a 2016 peak. With a tighter research budget than rivals, the company has struggled to keep up with devices such as Juul and Philip Morris’s IQOS, which heats tobacco without burning it. After years of shrugging off that market in favour of vaping products, Imperial recently introduced its first heated-tobacco device in Japan.
Imperial’s smoking-alternative business remains unprofitable but will move toward breaking even through 2020, Chief Executive Officer Alison Cooper said on a call with investors. The UK-based maker of Winston cigarettes said earnings per share were roughly flat at constant currencies and sales rose about 2% in the 12 months through September.
"It will be bumpy over the coming months, and there may be some short-term pain," Cooper said. Regulation will weed out the industry, leaving a few responsible companies, she added. "Therefore there will be a much better competitive environment."
The Trump administration said earlier this month that it would soon remove all flavoured e-cigarette nicotine pods from the market, and only allow them back in stores after they gained approval from the Food and Drug Administration. Several US states have moved to restrict vaping, and Walmart has decided to stop selling e-cigarettes in its home market.
The entire industry has been shuddering, not just the small independent vape companies that may have a harder time dealing with stricter policies from the FDA. In the past month, British American Tobacco said that it plans to cut 2 300 jobs and Japan Tobacco announced it will eliminate 3 720 positions. BAT shares fell as much as 4.8% Thursday.
Imperial’s sales of smoking alternatives rose about 50% this fiscal year, slowing from the breakneck 200% pace of the first half. The company also cited a tougher market for tobacco in countries such as Australia.
Several potential buyers have expressed interest in its premium cigar business, Imperial also said. The company has put the unit up for sale as part of a plan to raise as much as $2.5bn (about R37bn) from asset disposals.